Bioscience

← Back

Dr. James Nyagwange

Post-Doc


Publications

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.
Kagucia, E. W., Ziraba, A. K., Nyagwange, J., Kutima, B., Kimani, M., Akech, D., Ng'oda, M., Sigilai, A., Mugo, D., Karanja, H., Gitonga, J., Karani, A., Toroitich, M., Karia, B., Otiende, M., Njeri, A., Aman, R., Amoth, P., Mwangangi, M., Kasera, K., Ng'ang'a, W., Voller, S., Ochola-Oyier, L. I., Bottomley, C., Nyaguara, A., Munywoki, P. K., Bigogo, G., Maitha, E., Uyoga, S., Gallagher, K. E., Etyang, A. O., Barasa, E., Mwangangi, J., Bejon, P., Adetifa, I. M. O., Warimwe, G. M., Scott, J. A. G., Agweyu, A.
Influenza Other Respir Viruses, (2023). 17:e13173

Symptom prevalence and secondary attack rate of SARS-CoV-2 in rural Kenyan households: A prospective cohort study.
Gallagher, K. E., Nyiro, J., Agoti, C. N., Maitha, E., Nyagwange, J., Karani, A., Bottomley, C., Murunga, N., Githinji, G., Mutunga, M., Ochola-Oyier, L. I., Kombe, I., Nyaguara, A., Kagucia, E. W., Warimwe, G., Agweyu, A., Tsofa, B., Bejon, P., Scott, J. A. G., Nokes, D. J.
Influenza Other Respir Viruses, (2023). 17:e13185

A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies.
Ramirez Valdez, K., Nzau, B., Dorey-Robinson, D., Jarman, M., Nyagwange, J., Schwartz, J. C., Freimanis, G., Steyn, A. W., Warimwe, G. M., Morrison, L. J., Mwangi, W., Charleston, B., Bonnet-Di Placido, M., Hammond, J. A.
Vaccines (Basel), (2023). 11:

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021.
Etyang, A. O., Adetifa, I., Omore, R., Misore, T., Ziraba, A. K., Ng'oda, M. A., Gitau, E., Gitonga, J., Mugo, D., Kutima, B., Karanja, H., Toroitich, M., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Amoth, P., Mwangangi, M., Kasera, K., Ng'ang'a, W., Akech, D., Sigilai, A., Karia, B., Karani, A., Voller, S., Agoti, C. N., Ochola-Oyier, L. I., Otiende, M., Bottomley, C., Nyaguara, A., Uyoga, S., Gallagher, K., Kagucia, E. W., Onyango, D., Tsofa, B., Mwangangi, J., Maitha, E., Barasa, E., Bejon, P., Warimwe, G. M., Scott, J. A. G., Agweyu, A.
PLOS Glob Public Health, (2022). 2:e0000883

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.
Nyagwange, J., Kutima, B., Mwai, K., Karanja, H. K., Gitonga, J. N., Mugo, D., Sein, Y., Wright, D., Omuoyo, D. O., Nyiro, J. U., Tuju, J., Nokes, D. J., Agweyu, A., Bejon, P., Ochola-Oyier, L. I., Scott, J. A. G., Lambe, T., Nduati, E., Agoti, C., Warimwe, G. M.
Int J Infect Dis, (2022). 127:11-16

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.
Lucinde, R. K., Mugo, D., Bottomley, C., Karani, A., Gardiner, E., Aziza, R., Gitonga, J. N., Karanja, H., Nyagwange, J., Tuju, J., Wanjiku, P., Nzomo, E., Kamuri, E., Thuranira, K., Agunda, S., Nyutu, G., Etyang, A. O., Adetifa, I. M. O., Kagucia, E., Uyoga, S., Otiende, M., Otieno, E., Ndwiga, L., Agoti, C. N., Aman, R. A., Mwangangi, M., Amoth, P., Kasera, K., Nyaguara, A., Ng'ang'a, W., Ochola, L. B., Namdala, E., Gaunya, O., Okuku, R., Barasa, E., Bejon, P., Tsofa, B., Ochola-Oyier, L. I., Warimwe, G. M., Agweyu, A., Scott, J. A. G., Gallagher, K. E.
PLoS One, (2022). 17:e0265478

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations.
Nyagwange, J., Kutima, B., Mwai, K., Karanja, H. K., Gitonga, J. N., Mugo, D., Uyoga, S., Tuju, J., Ochola-Oyier, L. I., Ndungu, F., Bejon, P., Agweyu, A., Adetifa, I. M. O., Scott, J. A. G., Warimwe, G. M.
J Clin Virol, (2022). 146:105061

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.
Etyang, A. O., Lucinde, R., Karanja, H., Kalu, C., Mugo, D., Nyagwange, J., Gitonga, J., Tuju, J., Wanjiku, P., Karani, A., Mutua, S., Maroko, H., Nzomo, E., Maitha, E., Kamuri, E., Kaugiria, T., Weru, J., Ochola, L. B., Kilimo, N., Charo, S., Emukule, N., Moracha, W., Mukabi, D., Okuku, R., Ogutu, M., Angujo, B., Otiende, M., Bottomley, C., Otieno, E., Ndwiga, L., Nyaguara, A., Voller, S., Agoti, C. N., Nokes, D. J., Ochola-Oyier, L. I., Aman, R., Amoth, P., Mwangangi, M., Kasera, K., Ng'ang'a, W., Adetifa, I. M. O., Wangeci Kagucia, E., Gallagher, K., Uyoga, S., Tsofa, B., Barasa, E., Bejon, P., Scott, J. A. G., Agweyu, A., Warimwe, G. M.
Clin Infect Dis, (2022). 74:288-293

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.
Nyagwange, J., Ndwiga, L., Muteru, K., Wamae, K., Tuju, J., Testing Team, C., Kutima, B., Gitonga, J., Karanja, H., Mugo, D., Kasera, K., Amoth, P., Murunga, N., Babu, L., Otieno, E., Githinji, G., Nokes, D. J., Tsofa, B., Orindi, B., Barasa, E., Warimwe, G., Agoti, C. N., Bejon, P., Ochola-Oyier, L. I.
Wellcome Open Res, (2022). 7:69

Serosurveillance for SARS-CoV-2 Antibodies in a cohort of Health Care Workers in Kenya..
Etyang, A. O., Lucinde, R., Gitonga, J. N., Kalu, C., Karani, A., Nyagwange, J., Mugo, D., Karanja, H. K., Tuju, J., Mutiso, A., Maroko, H., Okubi, L., Maitha, E., Mukabi, D., The HCW SARS-CoV-2 Serosurveillance Team., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng’ang’a, W., Nyaguara, A., Voller, S., Otiende, M., Bottomley, C., Agoti, C. N., Ochola-Oyier, L. I., Adetifa, I.M.O., Gallagher, K. E., Uyoga, S., Barasa, E., Bejon, P., Tsofa, B., Agweyu, A., Warimwe, G. M., Scott, J. A. G.
1st International Conference on Public Health in Africa (CPHIA), (2021). :